Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Hugo Harrod
AddedMar 31, 2024
UpdatedMay 31, 2026
Hugo Harrod

Hugo Harrod

Board Member, AccuVein

CrunchbaseLinkedIn

Hugo Harrod's Career

AccuVein
AccuVein

Medford, NY, US

Board Member· Board
Vertos Medical
Vertos Medical

Aliso Viejo, CA, US

Board Member· Board
Nalu Medical
Nalu Medical

Carlsbad, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Hugo Harrod's Career

AccuVein
AccuVein
Series B$69.3M1102006Medford, NY, US
Board Member· Board

Leadership at AccuVein

Ron GoldmanRon GoldmanFounder & CEO
Scott H CramerScott H CramerBoard Member

Similar to AccuVein

NextVeinNextVeinPort Jefferson Station, NY, USMedical Devicesest. 2021NextVeinPort Jefferson Station, NY, US · est. 2021

NextVein offers affordable, augmented reality vein-finding tools for efficient healthcare.

Seed · $895k2
VascuLogicVascuLogicPiscataway, NJ, USMedical Devicesest. 2010VascuLogicPiscataway, NJ, US · est. 2010

VascuLogic creates image-guided medical devices for precise venipuncture and lab-on-chip diagnostic systems.

Angel · $149.4k6
Access VascularAccess VascularBedford, MA, USMedical Devicesest. 2015Access VascularBedford, MA, US · est. 2015

Access Vascular: Innovating venous access with novel hydrophilic-based medical devices.

Series C · $57.1M47
InnoVeinInnoVeinSan Carlos, CA, USMedical Devicesest. 2015InnoVeinSan Carlos, CA, US · est. 2015

InnoVein: A medical device company specializing in implantable valves for venous insufficiency treatment.

Seed · $10.8M
Vertos Medical
Vertos Medical
Series C$177.8M1632005Aliso Viejo, CA, US
Board Member· Board

Leadership at Vertos Medical

Don SchomerDon SchomerCo-Founder
Eric WichemsEric WichemsCEO
Dan WatkinsDan WatkinsBoard Member
Dave SolsbergDave SolsbergCo-Founder
Ittai HarelIttai HarelBoard Member
Mike BoggsMike BoggsBoard Member

Similar to Vertos Medical

Vertebral TechnologiesVertebral TechnologiesMinnetonka, MN, USMedical Devicesest. 2005Vertebral TechnologiesMinnetonka, MN, US · est. 2005

Vertebral Technologies: Innovating implantable spinal devices for advanced medical solutions.

Series B · $8.6M25
VerteCoreVerteCoreJackson, MS, USMedical Devicesest. 2015VerteCoreJackson, MS, US · est. 2015

VerteCore Technologies designs innovative, non-surgical devices for spinal disorders, offering cost-effective back pain relief and reducing the need for hospitalization.

Seed · $182.5k30
Spinal SimplicitySpinal SimplicityOverland Park, KS, USMedical Devicesest. 2008Spinal SimplicityOverland Park, KS, US · est. 2008

Medical device firm, Spinal Simplicity, innovates minimally invasive solutions for complex spinal issues.

Series D · $37.8M70
Empirical SpineEmpirical SpineSan Carlos, CA, USMedical Devicesest. 2015Empirical SpineSan Carlos, CA, US · est. 2015

Empirical Spine: Innovating minimally invasive solutions for degenerative lumbar spinal disorders.

Series B · $10M8
Nalu Medical
Nalu Medical
Series E$180.9M1912014Carlsbad, CA, US
Board Member· Board

Leadership at Nalu Medical

Thomas WestThomas WestCEO
Daniel PivonkaDaniel PivonkaCo-Founder
Mike PartschMike PartschCo-Founder
Juliet Tammenoms BakkerJuliet Tammenoms BakkerBoard Member
Lee HartleyLee HartleyCo-Founder
William J. DawsonWilliam J. DawsonBoard Member

Hugo Harrod's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Hugo Harrod

Kevin ChengKevin ChengBoard Member · OssioKyle DempseyKyle DempseyBoard Member · GT Medical TechnologiesAkhilesh PathipatiAkhilesh PathipatiBoard Member · NeurolensDan GrauDan GrauCEO · MVM PartnersJon MarshallJon MarshallBoard Member · Ancient NutritionStuart NagaeStuart NagaeBoard Member · CivicEye